Literature DB >> 25358730

Expression of insulin-like growth factor 2 receptor in corneal keratocytes during differentiation and in response to wound healing.

Richard N Bohnsack1, Debra J Warejcka1, Lingyan Wang2, Stephanie R Gillespie2, Audrey M Bernstein2, Sally S Twining3, Nancy M Dahms1.   

Abstract

PURPOSE: Insulin-like growth factor 2 receptor (IGF2R) associates with ligands that influence wound healing outcomes. However, the expression pattern of IGF2R and its role in the cornea is unknown.
METHODS: Human keratocytes were isolated from donor corneas. Fibroblasts (fibroblast growth factor 2 [FGF2]-treated) or myofibroblasts (TGF-β1-treated) were analyzed for IGF2R and α-smooth muscle actin (α-SMA) expression by Western blotting and immunolocalization. Mouse corneas were wounded in vivo and porcine corneas ex vivo. The IGF2R and α-SMA protein expression were visualized and quantified by immunohistochemistry. The IGF2R gene expression in human corneal fibroblasts was knocked-down with targeted lentiviral shRNA.
RESULTS: The IGF2R is expressed in epithelial and stromal cells of normal human, mouse, and porcine corneas. The IGF2R increases (11.2 ± 0.4-fold) in the epithelial and (11.7 ± 0.9-fold) stromal layers of in vivo wounded mouse corneas. Double-staining with α-SMA- and IGF2R-specific antibodies reveals that IGF2R protein expression is increased in stromal myofibroblasts in the wounded cornea relative to keratocytes in the normal cornea (11.2 ± 0.8-fold). Human primary stromal keratocytes incubated with FGF2 or TGF-β1 in vitro demonstrate increased expression (2.0 ± 0.4-fold) of IGF2R in myofibroblasts relative to fibroblasts. Conversion of IGF2R shRNA-lentiviral particle transduced corneal fibroblasts to myofibroblasts reveals a dependence on IGF2R expression, as only 40% ± 10% of cells transduced converted to myofibroblasts compared to 86% ± 3% in control cells.
CONCLUSIONS: The IGF2R protein expression is increased during corneal wound healing and IGF2R regulates human corneal fibroblast to myofibroblast differentiation. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  IGF2R; TGF-β1; cornea; myofibroblasts; wound healing

Mesh:

Substances:

Year:  2014        PMID: 25358730      PMCID: PMC4249949          DOI: 10.1167/iovs.14-15179

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  64 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 2.  Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.

Authors:  Alexis Desmoulière; Ian A Darby; Giulio Gabbiani
Journal:  Lab Invest       Date:  2003-12       Impact factor: 5.662

Review 3.  Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy.

Authors:  Marcelo V Netto; Rajiv R Mohan; Renato Ambrósio; Audrey E K Hutcheon; James D Zieske; Steven E Wilson
Journal:  Cornea       Date:  2005-07       Impact factor: 2.651

4.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

5.  Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy.

Authors:  Juan C Varela; Michael H Goldstein; Henry V Baker; Gregory S Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

Review 6.  uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.

Authors:  Bernd R Binder; Judit Mihaly; Gerald W Prager
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

7.  Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid.

Authors:  J X Kang; Y Li; A Leaf
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

8.  Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation.

Authors:  Robert J Wood; Mark D Hulett
Journal:  J Biol Chem       Date:  2007-12-11       Impact factor: 5.157

9.  The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration.

Authors:  Vladimír Leksa; Samuel Godár; Marek Cebecauer; Ivan Hilgert; Johannes Breuss; Ulrich H Weidle; Václav Horejsí; Bernd R Binder; Hannes Stockinger
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

10.  TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop.

Authors:  Yuanquan Yang; Zheng Wang; Hua Yang; Lingyan Wang; Stephanie R Gillespie; J Mario Wolosin; Audrey M Bernstein; Peter S Reinach
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  3 in total

1.  1,25-dihydroxyvitamin D3 inhibits corneal wound healing in an ex-vivo mouse model.

Authors:  Saadettin Sel; Stefanie Trau; Friedrich Paulsen; Thomas Kalinski; Gabriele I Stangl; Norbert Nass
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-21       Impact factor: 3.117

Review 2.  Circadian rhythms, refractive development, and myopia.

Authors:  Ranjay Chakraborty; Lisa A Ostrin; Debora L Nickla; P Michael Iuvone; Machelle T Pardue; Richard A Stone
Journal:  Ophthalmic Physiol Opt       Date:  2018-05       Impact factor: 3.117

Review 3.  The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease.

Authors:  Whitney L Stuard; Rossella Titone; Danielle M Robertson
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-03       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.